Concentric Medical

Mountain View, United States Founded: 1999 • Age: 27 yrs Acquired By Stryker
Endovascular devices are manufactured for removing clots in ischemic stroke.

About Concentric Medical

Concentric Medical is a Healthcare company based in Mountain View (United States) founded in 1999, and was acquired by Stryker in August 2011. Endovascular devices are manufactured for removing clots in ischemic stroke. Concentric Medical has raised $39.92 million across 4 funding rounds from investors including Stryker, Horizon Tech Finance and NEA. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is Concentric Medical, Inc. Its competitors include CoAxia, Sequent Medical and Metactive Medical; 3 of its 3 listed competitors have raised funding.

Company details

Concentric Medical manufactures and markets minimally invasive devices that are endovascularly delivered to the brain to remove blood clots that cause ischemic stroke. Concentric was treating acute ischemic stroke treatments with the launch of the first Merci Retriever in 2004. Most recently, the company successfully launched the Trevo Retriever in Europe in 2010. The Trevo Retriever is the first device utilizing Stentrieve technology, an approach to retrieving clots from the neurovasculature. The Trevo Retriever is currently being evaluated in the TREVO 2 Trial, a pivotal clinical trial investigating the safety and efficacy of the Trevo Retriever.

Operational Areas
Key Metrics
  • Total Equity Funding
    $39.92M (USD)

    in 4 rounds

  • Latest Funding Round
    $15M (USD), Series D

    Jan 2009

  • Investors
    Stryker

    & 5 more

  • Acquired by
    Stryker

    (Aug 2011)

Funding Insights of Concentric Medical

Concentric Medical has successfully raised a total of $39.92M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $15 million completed in January 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $39.92M
  • Total Rounds 4
  • Last Round Series D β€” $15M
  • First Round $12M

    (Aug 2002)

  • Investors Count 5

All 4 funding rounds of Concentric Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2009$15MSeries D––
Feb 2008$15MDebt – Venture––
Oct 2005$12.92MSeries C––
–
Aug 2002$12MSeries B––
Valuation history

6 investors in total: 6 institutional.

Investors in Concentric Medical

Concentric Medical has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Stryker, Horizon Tech Finance and NEA.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital investments are offered to startups by NEA.
nea.comMenlo Park, United States
Structured debt is provided to life sciences and technology firms.
2004horizontechfinance.comFarmington, United States
proquestvc.com
Seed-to-growth investments are made in US and Europe.
nvpllc.comNew Providence, United States
neuroventures.com
3D-printed orthopedic products are manufactured for medical applications.
1941stryker.comKalamazoo, United States
Premium access

Investor details for Concentric Medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Concentric Medical

4 dated milestones of Concentric Medical across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Concentric Medical is founded.
  2. Funding First funding round of $12.0M.
  3. Funding Latest funding round, Series D, of $15.0M.
  4. Exit Acquired by Stryker.

Competitors of Concentric Medical

Concentric Medical has 3 listed competitors in our database, 3 of them funded. They include CoAxia, Sequent Medical and Metactive Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
coaxia.com1999Maple Grove, United States$72.6M
Catheter-based treatment for cerebral ischemia
sequentmedical.com2007Aliso Viejo, United States$65.26M1,028
Catheter-based neurovascular devices for aneurysm treatment are developed.
metactivemedical.com2011Olathe, United States$4.7M31
Endovascular devices are developed for peripheral and neurovascular disease treatments.
Premium access

Detailed competitors of Concentric Medical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Neurology

3 companies that operate in the same segment as Concentric Medical (Neurology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
2013San Francisco, California, United StatesUSD 214.78 MUSD 21.05 M211
Developer of therapeutics for psychiatric and neurologic diseases
2002New York, New York, United StatesUSD 80.87 MUSD 250.31 M600
Biologics platform developed for intracellular delivery in rare diseases.
2016Boston, Massachusetts, United StatesUSD 175.25 MUSD 25.42 M183
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Concentric Medical

Concentric Medical was founded in 1999 and raised its 1st funding round 3 years after it was founded.

Concentric Medical is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.

Concentric Medical is a funded company, having raised a total of $39.92M across 4 funding rounds to date. The company's 1st funding round was a Series B of $12M, raised on Aug 2002.

Concentric Medical manufactures and markets minimally invasive devices that are endovascularly delivered to the brain to remove blood clots that cause ischemic stroke. Concentric was treating acute ischemic stroke treatments with the launch of the first Merci Retriever in 2004. Most recently, the company successfully launched the Trevo Retriever in Europe in 2010. The Trevo Retriever is the first device utilizing Stentrieve technology, an approach to retrieving clots from the neurovasculature. The Trevo Retriever is currently being evaluated in the TREVO 2 Trial, a pivotal clinical trial investigating the safety and efficacy of the Trevo Retriever.

Concentric Medical's top competitors include Sequent Medical, Metactive Medical and CoAxia.

Concentric Medical has 6 investors. Key investors include Stryker, Horizon Tech Finance, NEA, ProQuest Investments, and New Venture Partners.

Concentric Medical operates through Concentric Medical, Inc.

Yes. Concentric Medical was acquired by Stryker in August 2011.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available